Co-financed by the European Union under the European Funds for a Modern Economy 2021–2027 programme
European Funds for a Modern Economy Programme
Priority 2. Innovation-friendly Environment
Call FENG.02.04-IP.04-001/25 – Research Infrastructure for a Modern Economy – path for projects of institutions with a network-based character
Total project value:
248,337,770.24 PLN
Total funding:
180,481,656.59 PLN
Łukasiewicz – PORT project value:
11,026,039.23 PLN
Łukasiewicz – PORT funding:
8,804,914.39 PLN
Project implementation period:
Project manager:
Consortium leader: Institute of Bioorganic Chemistry, Polish Academy of Sciences
Consortium members:
- Łukasiewicz Research Network – PORT Polish Center for Technology Development (Łukasiewicz – PORT)
- Institute of Human Genetics, Polish Academy of Sciences
- Nencki Institute of Experimental Biology, Polish Academy of Sciences
- Poznań University of Technology
- University of Warsaw
- Medical University of Białystok
- University of Łódź
- University of Gdańsk
- Jagiellonian University
- Stefan Cardinal Wyszyński National Institute of Cardiology –National Research Institute
- Maria Skłodowska-Curie National Research Institute of Oncology
Genomics for Poland (G4PL) is a strategic research and development project implemented by a consortium of 12 leading Polish scientific and research institutions. Its aim is to create a nationwide, modern infrastructure for advanced genomic research.
The project addresses a key gap in the national R&D system — the absence of a coherent, interoperable, and scalable network enabling the generation, processing, storage, and sharing of genomic data in accordance with European and international standards. Progress in precision medicine and the development of modern diagnostic and therapeutic tools are now inseparably linked with advances in genomics. Genomics not only enables the identification of individual genetic predispositions and the selection of personalized therapies but also allows the prediction of adverse drug reactions and supports national health policy.
A crucial role in this regard is played by population genomics, based on high-throughput sequencing of genomes from large and representative groups of citizens. In EU member states, such development takes place within integrated infrastructure and research programmes such as Genome of Europe or the 1+MG initiative. Participation in these initiatives requires member states to possess a coherent and scalable infrastructure: sequencing laboratories, biobanks, bioinformatics systems, national data repositories, and harmonized legal, ethical, and quality frameworks. Poland currently lacks such infrastructure, which results in weak population representation in European databases, limited accuracy of clinical algorithms, hindered technology transfer, and low efficiency in the use of data in diagnostics, research, and industrial applications.
The G4PL project aims to establish a comprehensive genomic infrastructure of strategic importance for the Polish science, healthcare, and innovation system. The project will create a nationwide, interoperable network of accredited sequencing laboratories, a national data repository, and a distributed biobank network. This infrastructure will support both scientific and industrial activities — including the development of innovative solutions in personalized medicine, bioinformatics, biotechnology, and IT. The project includes infrastructural activities (procurement and installation of research equipment, construction works), IT development (analytical tools and databases), and organizational measures (standardization of procedures, ensuring interoperability and compliance with GDPR and FAIR principles). The project’s implementation will enable the effective use of genomic data in research, diagnostics, and industry.
At Łukasiewicz – PORT, the project includes the development of a genomic platform and training to enhance staff qualifications.
